NAT-GEFITINIB

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: 8e3d6b5b23ac1f2e
Drug Approval Canada Name: NAT-GEFITINIB
Product Name: NAT-GEFITINIB
Status: Marketed
Status Date: 2019-11-13
Original Market Date: 2019-11-13
Din: 02491796
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EB01 GEFITINIB
Atc Name: l 01 eb 01
Aig Number: 0149783001
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

GEFITINIB

250 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8e3d6b5b23ac1f2e

Type

Standard